Pia Burman
Physician
Publications
Displaying of publications. Sorted by year, then title.
Aggressive pituitary tumors and pituitary carcinomas : from pathology to treatment
Pia Burman, Olivera Casar-Borota, Luis Gustavo Perez-Rivas, Olaf M Dekkers
(2023) The Journal of clinical endocrinology and metabolism
Journal articleIncreased Mortality Persists after Treatment of Cushing's Disease : A Matched Nationwide Cohort Study
Daniel Bengtsson, Oskar Ragnarsson, Katarina Berinder, Per Dahlqvist, Britt Edén Engström, et al.
(2022) Journal of the Endocrine Society, 6
Journal articleLong-term outcomes of patients with acromegaly : a report from the Swedish Pituitary Register
Steinunn Arnardóttir, Jacob Järås, Pia Burman, Katarina Berinder, Per Dahlqvist, et al.
(2022) European Journal of Endocrinology, 186 p.329-339
Journal articleNatural history and surgical outcome of Rathke's cleft cysts—A study from the Swedish Pituitary Registry
Maria Petersson, Katarina Berinder, Britt Eden Engström, Erika Tsatsaris, Bertil Ekman, et al.
(2022) Clinical Endocrinology, 96 p.54-61
Journal articlePituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis : analysis of the KIMS database
Philippe Touraine, Yempabou Sagna, Anders F. Mattsson, Pia Burman, André P. Van Beek, et al.
(2022) Yosetsu Gakkai Shi/Journal of the Japan Welding Society, 187 p.373-381
Journal articleAggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
P. Burman, Olaf M Dekkers
(2022) European Journal of Endocrinology, 187 p.593-605
Journal articlePsychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up : A Nationwide Study
Daniel Bengtsson, Oskar Ragnarsson, Katarina Berinder, Per Dahlqvist, Britt Edén Engström, et al.
(2021) The Journal of clinical endocrinology and metabolism, 106 p.1750-1760
Journal articleCorticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
Olivera Casar-Borota, Henninǵbünsow Boldt, Brittédén Engström, Marianne Skovsager Andersen, Bertrand Baussart, et al.
(2021) Journal of Clinical Endocrinology and Metabolism, 106 p.1183-1194
Journal article11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman with Congenital Adrenal Hyperplasia
Pia Burman, Henrik Falhammar, Erik Waldenström, Anders Sundin, Ulrika Bitzén
(2021) Journal of Clinical Endocrinology and Metabolism, 106 p.675-679
Journal articleImproved Urinary Cortisol Metabolome in Addison Disease : A Prospective Trial of Dual-Release Hydrocortisone
Stéphanie Espiard, Johanna McQueen, Mark Sherlock, Oskar Ragnarsson, Ragnhildur Bergthorsdottir, et al.
(2021) The Journal of clinical endocrinology and metabolism, 106 p.814-825
Journal articlePrevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease : a systematic review and meta-analysis
Eleni Papakokkinou, Marta Piasecka, Hanne Krage Carlsen, Dimitrios Chantzichristos, Daniel S. Olsson, et al.
(2021) Pituitary, 24 p.797-809
Journal articleTemozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
Pia Burman, Lydia Lamb, Ann McCormack
(2020) Reviews in Endocrine and Metabolic Disorders, 21 p.263-276
Journal article reviewEarly versus late initiation of GH replacement in adult-onset hypopituitarism
Mark R. Postma, Pia Burman, André P. van Beek
(2020) Endocrine Connections, 9 p.687-695
Journal articleReference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome
Nils Bäcklund, Göran Brattsand, Marlen Israelsson, Oskar Ragnarsson, Pia Burman, et al.
(2020) European Journal of Endocrinology, 182 p.569-582
Journal articleExcess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission : A Swedish Nationwide Study
Eleni Papakokkinou, Daniel S. Olsson, Dimitrios Chantzichristos, Per Dahlqvist, Elin Segerstedt, et al.
(2020) The Journal of clinical endocrinology and metabolism, 105
Journal articleAre aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
Jacqueline Trouillas, Marie Lise Jaffrain-Rea, Alexandre Vasiljevic, Olaf Dekkers, Vera Popovic, et al.
(2020) Reviews in Endocrine and Metabolic Disorders, 21 p.243-251
Journal article reviewPituitary Metastases : A Nationwide Study on Current Characteristics with Special Reference to Breast Cancer
Fredrika Schill, Margareta Nilsson, Daniel S. Olsson, Oskar Ragnarsson, Katarina Berinder, et al.
(2019) Journal of Clinical Endocrinology and Metabolism, 104 p.3379-3388
Journal articleThe incidence of Cushing’s disease : a nationwide Swedish study
Oskar Ragnarsson, Daniel S. Olsson, Dimitrios Chantzichristos, Eleni Papakokkinou, Per Dahlqvist, et al.
(2019) Pituitary, 22 p.179-186
Journal articleChange in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy
Charlotte Höybye, Pia Burman, Ulla Feldt-Rasmussen, Judith Hey-Hadavi, Ferah Aydin, et al.
(2019) European Journal of Endocrinology, 181 p.629-638
Journal articleTumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
D. Bengtsson, H. D. Schrøder, K. Berinder, D. Maiter, C. Hoybye, et al.
(2018) Endocrine, 62 p.737-739
Journal article (letter)Temporal relationship of sleep apnea and acromegaly : a nationwide study
Konstantina Vouzouneraki, Karl A. Franklin, Maria Forsgren, Maria Wärn, Jenny Tiberg Persson, et al.
(2018) Endocrine, 62 p.456-463
Journal articleAggressive pituitary tumours and carcinomas : two sides of the same coin?
Jacqueline Trouillas, Pia Burman, Ann McCormack, Stephan Petersenn, Vera Popovic, et al.
(2018) European Journal of Endocrinology, 178
Journal article reviewTreatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack, Olaf M. Dekkers, Stephan Petersenn, Vera Popovic, Jacqueline Trouillas, et al.
(2018) European Journal of Endocrinology, 178 p.265-276
Journal articleRelative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
Kevin C.J. Yuen, Anders F. Mattsson, Pia Burman, Eva Marie Erfurth, Cecilia Camacho-Hubner, et al.
(2018) Journal of Clinical Endocrinology and Metabolism, 103 p.768-777
Journal articleEuropean Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot, Pia Burman, Ann McCormack, Anthony Heaney, Stephan Petersenn, et al.
(2018) European Journal of Endocrinology, 178 p.1-24
Journal articleCorticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
Daniel Bengtsson, Patrick Joost, Christos Aravidis, Marie Askmalm Stenmark, Ann Sofie Backman, et al.
(2017) The Journal of clinical endocrinology and metabolism, 102 p.3928-3932
Journal articleDevelopment of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Aart Jan van der Lely, Roy Gomez, Andreas Pleil, Xavier Badia, Thierry Brue, et al.
(2017) Pituitary, 20 p.692-701
Journal articleA permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?
Pia Burman, Olaf M Dekkers
(2017) Endocrine, 57 p.356-358
Journal article (letter)Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary/sellar lesions
Pia Burman, Andre P. Van Beek, Beverly M K Biller, Cecilia Camacho-Hübner, Anders F. Mattsson
(2017) Journal of Clinical Endocrinology and Metabolism, 102 p.1051-1058
Journal articleLong-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
Anna G. Nilsson, Ragnhildur Bergthorsdottir, Pia Burman, Per Dahlqvist, Bertil Ekman, et al.
(2017) European Journal of Endocrinology, 176 p.715-725
Journal articleLimited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
Pia Burman, Britt Edén-Engström, Bertil Ekman, F Anders Karlsson, Erik Schwarcz, et al.
(2016) European Journal of Endocrinology, 174 p.17-24
Journal articleGrowth Hormone Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
David B Allen, Philippe Backeljauw, Martin Bidlingmaier, Beverly Biller, Margaret Boguszewski, et al.
(2015) European Journal of Endocrinology
Journal articleTruncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues - Observations in two patients with acromegaly and severe headache.
Djordje Marina, Pia Burman, Marianne Klose, Olivera Casar-Borota, Raúl M Luque, et al.
(2015) Growth Hormone & Igf Research, 25 p.262-267
Journal articleESE guidelines, why and how.
Olaf M Dekkers, Pia Burman
(2015) European Journal of Endocrinology, 173 p.1-2
Journal article (comment)Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
Daniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen, Dominique Maiter, Katarina Berinder, et al.
(2015) Journal of Clinical Endocrinology and Metabolism, 100 p.1689-1698
Journal articleProspective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
Anna G Nilsson, Claudio Marelli, David Fitts, Ragnhildur Bergthorsdottir, Pia Burman, et al.
(2014) European Journal of Endocrinology, 171 p.369-377
Journal articleGiant prolactinomas in women
Etienne Delgrange, Gerald Raverot, Marie Bex, Pia Burman, Benedicte Decoudier, et al.
(2014) European Journal of Endocrinology, 170 p.31-38
Journal articleNational Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden.
Lisa Onnestam, Katarina Berinder, Pia Burman, Per Dahlqvist, Britt Edén Engström, et al.
(2013) Journal of Clinical Endocrinology and Metabolism, 98 p.626-635
Journal articleDeaths Among Adult Patients with Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality.
Pia Burman, A F Mattsson, G Johannsson, C Höybye, Helene Holmer, et al.
(2013) Journal of Clinical Endocrinology and Metabolism, 98 p.1466-1475
Journal articleImproved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation.
G Johannsson, A G Nilsson, R Bergthorsdottir, Pia Burman, P Dahlqvist, et al.
(2011) The Journal of clinical endocrinology and metabolism, 97 p.473-481
Journal articleFavorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency
A. P. Jorgensen, K. J. Fougner, T. Ueland, O. Gudmundsen, Pia Burman, et al.
(2011) Growth Hormone & Igf Research, 21 p.69-75
Journal articleInterleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.
Thor Ueland, Anders P Jørgensen, Kristin Godang, Kristian J Fougner, Pål Aukrust, et al.
(2011) Clinical Endocrinology, Dec p.60-66
Journal articleLarge fat and skin necroses after deep subcutaneous injections of a slow-release somatostatin analogue in a woman with acromegaly.
Pia Burman, Jan Besjakov, Tore Svensjö
(2010) Growth Hormone & Igf Research, Dec p.438-440
Journal articleImproved Quality of Life in Patients with Primary Adrenal Insufficiency by Using a Novel Once-Daily Dual Release Hydrocortisone Tablet: A Randomised Controlled, Cross-Over Trial.
G. Johannsson, A. G. Nilsson, R. Bergthorsdottir, Pia Burman, B. Eden Engstrom, et al.
(2010) Endocrine Reviews, 31
Conference paper: abstractRecurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis.
Olaf M Dekkers, Joep Lagro, Pia Burman, Jens Otto Jørgensen, Johannes A Romijn, et al.
(2010) The Journal of clinical endocrinology and metabolism, 95 p.43-51
Journal articleAssessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations
Susana Igreja, Harvinder S. Chahal, Scott A. Akker, Maria Gueorguiev, Vera Popovic, et al.
(2009) Clinical Endocrinology, 70 p.259-264
Journal articleFollow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
Camilo Jimenez, Pia Burman, Roger Abs, David R. Clemmons, William N. Drake, et al.
(2008) European Journal of Endocrinology, 159 p.517-523
Journal articleGender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant
Craig Parkinson, Pia Burman, Michael Messig, Peter J. Trainer
(2007) Journal of Clinical Endocrinology and Metabolism, 92 p.190-195
Journal articleEffects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study
Mahesh Sathiavageeswaran, Pia Burman, David Lawrence, Alan G. Harris, Marina G. Falleti, et al.
(2007) European Journal of Endocrinology, 156 p.439-447
Journal articleThe effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: A meta-analysis of the current literature
MG Falleti, P Maruff, Pia Burman, A Harris
(2006) Psychoneuroendocrinology, 31 p.681-691
Journal articleLow-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
J Bollerslev, J Hallen, KJ Fougner, AP Jorgensen, C Kristo, et al.
(2005) European Journal of Endocrinology, 153 p.379-387
Journal article